KDx Diagnostics
Campbell, US · Founded 2016 · Delaware corporation
KDx Diagnostics develops diagnostic tests for early detection and management of cancer, including the URO17 non-invasive urine test for bladder cancer based on the Keratin 17 biomarker. The URO17 test is offered in the US as a Laboratory Developed Test through reference laboratories and as a CE-IVD kit outside the US.
Founders & leadership
KDx Diagnostics was founded in 2016 by Shahram Shawn Gholami.
SS
Shahram Shawn GholamiFounder
SJ
Sholeh JahanfardExecutive
NK
Nam KimExecutive
Reported raises · per SEC filings
Form D private placements$1.7M disclosed across 4 rounds · 2017–2019
▶$820KraisedMay 2019 · 16 investors · BiotechnologyRule 506(b)
▶$820KraisedMay 2019 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sholeh JahanfardExecutive Officer, Director
- Nam KimExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $820K
- Minimum investment
- $10K
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$300KraisedMar 2019 · 2 investors · BiotechnologyRule 506(b)
▶$300KraisedMar 2019 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sholeh JahanfardExecutive Officer, Director
- Nam KimExecutive Officer, Director
- Offering amount
- $300K
- Amount sold
- $300K
- Minimum investment
- $100K
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$100KraisedAug 2018 · 2 investors · BiotechnologyRule 506(b)
▶$100KraisedAug 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sholeh JahanfardExecutive Officer, Director
- Nam KimExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $100K
- Minimum investment
- $20K
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$440KraisedDec 2017 · 6 investors · BiotechnologyRule 506(b)
▶$440KraisedDec 2017 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sholeh JahanfardExecutive Officer, Director
- Nam KimExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $440K
- Minimum investment
- $20K
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapAmerican Cancer Society (ACS)26 shared keywordsThe American Cancer Society is a nonprofit cancer-fighting organization that combats cancer through advocacy, research, and patient support. It provides information, guidance, caregiver resources, screening guidance, and clinical trial navigation for cancer patients, families, and caregivers, and funds cancer research.
Cancerresearchuk22 shared keywordsCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
MD Anderson Cancer Center21 shared keywordsUT MD Anderson is a cancer hospital providing cancer treatment, prevention, clinical care, and research, including new therapies and clinical trials for cancer patients. It is ranked among the top hospitals in the U.S. for cancer care.
Fred Hutch14 shared keywordsFred Hutch is a cancer treatment and research organization providing patient care, clinical trials, and research into the prevention, early detection, and treatment of cancer, HIV, and other diseases. It serves patients across the Pacific Northwest and also functions as the cancer program for UW Medicine.
Companies competing with KDx Diagnostics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does KDx Diagnostics do?
- KDx Diagnostics develops diagnostic tests for early detection and management of cancer, including the URO17 non-invasive urine test for bladder cancer based on the Keratin 17 biomarker. The URO17 test is offered in the US as a Laboratory Developed Test through reference laboratories and as a CE-IVD kit outside the US.
- Who founded KDx Diagnostics?
- KDx Diagnostics was founded by Shahram Shawn Gholami in 2016.
- How much funding has KDx Diagnostics raised?
- KDx Diagnostics has disclosed $1.7M raised across 4 rounds.
- Where is KDx Diagnostics headquartered?
- KDx Diagnostics is headquartered in Campbell, US.